TABLE 4.
Variables | Group | Model 1 |
Model 2 |
Model 3 |
|||
OR (95% CI) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | ||
MetS | Low active | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | |||
Moderate active | 0.86 (0.74–1.00) | 0.051 | 0.93 (0.79–1.10) | 0.406 | 0.89 (0.75–1.06) | 0.204 | |
High active | 0.60 (0.50–0.71) | <0.001 | 0.73 (0.60–0.88) | 0.001 | 0.69 (0.57–0.85) | <0.001 | |
High WC | Low active | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | |||
Moderate active | 0.85 (0.73–0.99) | 0.039 | 0.84 (0.70–1.00) | 0.061 | 0.81 (0.66–0.98) | 0.032 | |
High active | 0.59 (0.50–0.70) | <0.001 | 0.68 (0.56–0.84) | <0.001 | 0.66 (0.53–0.82) | <0.001 | |
High BP | Low active | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | |||
Moderate active | 0.99 (0.86–1.16) | 0.990 | 1.00 (0.85–1.20) | 0.930 | 1.02 (0.85–1.22) | 0.818 | |
High active | 0.94 (0.79–1.12) | 0.514 | 0.97 (0.81–1.16) | 0.721 | 0.97 (0.81–1.17) | 0.758 | |
High Glucose | Low active | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | |||
Moderate active | 1.00 (0.86–1.16) | 0.983 | 0.96 (0.82–1.22) | 0.609 | 0.98 (0.83–1.16) | 0.808 | |
High active | 0.88 (0.74–1.05) | 0.167 | 0.89 (0.74–1.06) | 0.186 | 0.87 (0.72–1.05) | 0.153 | |
High TG | Low active | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | |||
Moderate active | 0.95 (0.81–1.11) | 0.492 | 0.96 (0.82–1.12) | 0.603 | 0.94 (0.79–1.11) | 0.474 | |
High active | 0.67 (0.55–0.80) | <0.001 | 0.70 (0.58–0.85) | <0.001 | 0.70 (0.58–0.86) | <0.001 | |
Low HDL-C | Low active | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | |||
Moderate active | 0.76 (0.65–0.88) | <0.001 | 0.87 (0.74–1.02) | 0.084 | 0.85 (0.72–1.01) | 0.063 | |
High active | 0.56 (0.47–0.67) | <0.001 | 0.68 (0.57–0.82) | <0.001 | 0.70 (0.57–0.85) | <0.001 | |
Osteoporosis | Low active | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | |||
Moderate active | 0.62 (0.53–0.74) | <0.001 | 0.80 (0.66–0.97) | 0.021 | 0.80 (0.66–0.96) | 0.020 | |
High active | 0.46 (0.38–0.55) | <0.001 | 0.61 (0.48–0.76) | <0.001 | 0.61 (0.49–0.76) | <0.001 | |
Sarcopenia | Low active | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | |||
Moderate active | 0.77 (0.60–0.98) | 0.032 | 0.72 (0.57–0.92) | 0.010 | 0.76 (0.59–0.99) | 0.039 | |
High active | 0.73 (0.57–0.93) | 0.012 | 0.59 (0.46–0.76) | < 0.001 | 0.64 (0.49–0.84) | 0.001 | |
Obesity | Low active | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | |||
Moderate active | 0.89 (0.76–1.05) | 0.158 | 1.10 (0.93–1.30) | 0.267 | 1.14 (0.95–1.36) | 0.160 | |
High active | 0.47 (0.39–0.57) | <0.001 | 0.60 (0.49–0.74) | <0.001 | 0.57 (0.46–0.72) | <0.001 | |
SO | Low active | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | |||
Moderate active | 0.84 (0.60–1.18) | 0.304 | 0.85 (0.61–1.20) | 0.360 | 0.85 (0.59–1.22) | 0.366 | |
High active | 0.47 (0.30–0.75) | 0.002 | 0.48 (0.30–0.78) | 0.003 | 0.49 (0.30–0.81) | 0.005 |
Values are expressed as odds ratio (95% confidence interval). OR, odds ratio; CI, confidence interval; Mets, metabolic syndrome; WC, waist circumference; BP, blood pressure; TG, triglyceride; HDL, high-density lipoprotein, SO, sarcopenic obesity; Model 1, not adjusted; Model 2, adjusted for sex, sarcopenia, and obesity; Model 3, adjusted for sex, sarcopenia, and obesity, and osteoporosis.